Mobile

A randomized, double-blind, placebo-controlled study to assess the effect of Tamsulosin OCAS 0.4 mg tablets, once daily on nocturia, compared to placebo, in patients with lower urinary tract symptoms ...

Update Il y a 5 ans
Reference: EUCTR2005-001627-11

A randomized, double-blind, placebo-controlled study to assess the effect of Tamsulosin OCAS 0.4 mg tablets, once daily on nocturia, compared to placebo, in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To assess the effect of Tamsulosin OCAS 0.4 mg o.d. compared to placebo on improvement of nocturnal voiding frequency, in subjects with LUTS associated with BPH over 12 weeks.

Inclusion criteria

  • LUTS (lower urinary tract symptoms) associated with BPH (benign prostatic hyperplasia)

Links